Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination

참고문헌 (8)

1. Schultz NH, "Thrombosis and thrombocytopenia after ChAdOx1nCoV-19 vaccination", N Engl J Med, 384, pp.2124~2130 (2021)
2. See I, "US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021", JAMA, 325, pp.2448~2456 (2021)
3. Cines DB, "SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia", N Engl J Med, 384, pp.2254~2256 (2021)
4. Idiculla PS, "Cerebral venous thrombosis : a comprehensive review", Eur Neurol, 83, pp.369~379 (2020)
5. Coutinho JM, "The incidence of cerebral venous thrombosis : a cross-sectional study", Stroke, 43, pp.3375~3377 (2012)
6. Devasagayam S, "Cerebral venous sinus thrombosis incidence is higher than previously thought : a retrospective population-based study", Stroke, 47, pp.2180~2182 (2016)
7. "COVID-19 vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets" (2021)[URL]
8. MacNeil JR, "Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen(Johnson & Johnson)COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients—United States, April 2021", MMWR Morb Mortal Wkly Rep, 70, pp.651~656 (2021)

관련 논문AI추천